FDA Plans To Continue Diagnostics Reform Fight
Executive Summary
In a recent webinar about the agency’s current regulatory and legislative priorities, FDA Deputy Commissioner Andi Fristedt called the way diagnostics are now regulated “untenable.”
You may also be interested in...
Diagnostics Reform Out As Congress Reaches Year-End Omnibus Compromise
A measure that would have moved diagnostics regulation under the US Food and Drug Administration has been culled from the year-end omnibus spending package.
News We're Watching – 27 January
This feature compiles news briefs on a range of US regulatory and legal happenings. This week: Medtronic seeks HeartWare batteries; companies sign health equity pledge; insulin dosing app cleared; recall on field decontamination kits; and the renewal of an FDA panel.
Product Liability Missteps Top List Of Worst Legal Verdicts Of 2022
A recent webinar ranking last year’s best and worst legal verdicts said that product liability cases involving pelvic mesh and artificial lenses were the very worst.